FDA Label for Kaseha Pain Relieving Gel
View Indications, Usage & Precautions
Kaseha Pain Relieving Gel Product Label
The following document was submitted to the FDA by the labeler of this product Denali Natural Products. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredients
camphor 3.2%
capsaicin 0.15%
menthol 1.25%
methyl salicylate 10%
Purpose
pain relieving gel
Use
For the temporary relief of minor aches and pains of muscles and joints
Warnings
For external use only.
Otc - Do Not Use
Do not use otherwise than as directed.
Otc - When Using
When using this product • avoid contact with the eyes and mucous membranes
- do not apply to wounds or damaged skin • do not bandage tightly
Otc - Stop Use
Stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. Discontinue use if excessive irritation of the skin develops
Otc - Keep Out Of Reach Of Children
Keep out of reach of chilren. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Adults and children 3 years of age and older: Apply to the affected area not more than 3 to 4 times daily. • Children under 3 years of age: Consult a doctor.
Inactive Ingredients
Aloe vera extract, carbomer 940, eucalyptus globulus leaf essential oil, glycerin, guaiacum, phenoxyethanol, rosmarinus officinalis (rosemary) leaf oil, sodium acrylate/sodium acryloyldimethyltaurate copolymer (4000000 MW), triethanolamine, water.
Other
KASEHA
Pain Relieving Gel
4 fl oz (120mL)
DISTRIBUTED BY:
DENALI NATURAL PRODUCTS,
1411 N. BATAVIA ST STE 116
ORANGE, CA 92867
MADE IN MEXICO
TEL. 562-390-2873
Package Label.Principal Display Panel
* Please review the disclaimer below.